Editorial: effects of vedolizumab during pregnancy in the CONCEIVE study

Aliment Pharmacol Ther. 2020 Jan;51(2):307-308. doi: 10.1111/apt.15600.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Inflammatory Bowel Diseases*
  • Pregnancy
  • Pregnancy Outcome*
  • Tumor Necrosis Factor-alpha

Substances

  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • vedolizumab